HOSPITALAR 2026

Coury Medical is pleased to participate in HOSPITALAR 2026, held from May 19 to 22 at São Paulo Expo in Brazil. As one of the most influential healthcare industry events in Latin America, HOSPITALAR brings together medical device companies, healthcare professionals, distributors, and industry experts from around the world.

At Booth E-265, Coury Medical is showcasing its core interventional medical device portfolio, with a focus on solutions for coronary and peripheral vascular procedures. The exhibition provides an important opportunity for the company to present its technical capabilities, product development progress, and commitment to high-quality interventional care to the Latin American market.

During the event, the Coury Medical team has engaged in in-depth discussions with international visitors, local partners, and clinical professionals. These face-to-face conversations have offered valuable insights into regional healthcare needs, clinical practices, regulatory considerations, and market expectations in Brazil and the broader Latin American region.

For Coury Medical, participation in HOSPITALAR 2026 is not only a product showcase, but also an important step in strengthening global market engagement. By listening closely to local market feedback and building connections with potential partners, the company is laying a stronger foundation for future product adaptation, market development, and long-term international collaboration.

Coury Medical remains committed to clinical needs-driven innovation, with a continued focus on precision manufacturing, product reliability, and stable performance. Through ongoing investment in R&D and strict control over production processes, the company aims to provide interventional medical device solutions that meet diverse clinical requirements and support safer, more efficient procedures. 

Looking ahead, Coury Medical will continue to expand its global presence and bring reliable, high-quality, and accessible interventional solutions to more healthcare markets worldwide. HOSPITALAR 2026 marks another meaningful step in the company’s journey to connect Chinese medical device innovation with global clinical needs.